10/07/2026
The MD-PhD (Molecular Medicine) Program successfully held the ๐๐๐๐๐ ๐๐จ๐ฅ๐ฅ๐๐๐จ๐ซ๐๐ญ๐ข๐ฏ๐ ๐๐ฒ๐ฆ๐ฉ๐จ๐ฌ๐ข๐ฎ๐ฆ: ๐๐ข๐ซ๐ฎ๐ฌ๐๐ฌ, ๐๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ฌ๐ญ๐ข๐ ๐๐ง๐๐๐๐ญ๐ข๐จ๐ง๐ฌ, ๐๐ง๐ ๐๐จ๐ฌ๐ญ ๐๐๐ฌ๐ฉ๐จ๐ง๐ฌ๐ last July 1, 2026 at the UNILAB Conference Room, Henry Sy Sr. Medical Sciences Building, UP Manila College of Medicine.
The symposium opened with inspiring remarks from ๐๐๐๐ง ๐๐ซ. ๐๐ก๐๐ซ๐ฅ๐จ๐ญ๐ญ๐ ๐. ๐๐ก๐ข๐จ๐ง๐ , setting the stage for an engaging exchange of knowledge on infectious diseases, host immunity, and advances in molecular medicine.
We were honored to welcome ๐๐ซ. ๐๐ก๐๐ง๐ -๐๐ฎ๐ง๐ ๐๐ฎ as our guest speaker, who delivered a lecture entitled "๐ด๐๐ก๐๐๐ฆ๐ก๐๐๐๐๐ ๐ด๐ข๐ก๐๐๐๐ก๐๐๐๐๐๐๐ ๐๐ ๐ ๐๐๐ฃ๐๐ ๐ธ๐ก๐๐๐๐๐๐ฆ ๐๐ ๐ผ๐๐๐๐๐ก๐๐๐ข๐ ๐ท๐๐ ๐๐๐ ๐๐ ." His lecture highlighted the emerging role of anticytokine autoantibodies in susceptibility to infectious diseases and underscored the importance of integrating immunology into clinical research and patient care.
The symposium also featured presentations from distinguished researchers and clinicians from UP Manila, highlighting ongoing initiatives that leverage molecular medicine to address infectious diseases and other complex health conditions. ๐๐ก๐๐ง๐๐๐ฅ๐ฅ๐จ๐ซ ๐๐ซ. ๐๐ข๐๐ก๐๐๐ฅ ๐. ๐๐๐ shared updates on the ๐๐๐ผ๐ฟ๐ธ ๐น๐๐๐๐๐๐๐ ๐๐๐ก๐๐๐๐ก๐ ๐๐๐๐๐๐๐ก (Single Nucleotide Polymorphisms, Microbiome, and Inflammatory Biomarkers in Filipino Patients with Systemic Lupus Erythematosus), a multidisciplinary initiative investigating the genetic, immunological, and microbial factors underlying systemic lupus erythematosus (SLE) in Filipino patients. The project aims to deepen our understanding of disease mechanisms and support improved patient care. ๐๐ซ. ๐
๐ซ๐๐ง๐๐ข๐ฌ๐๐จ ๐. ๐๐๐ซ๐๐ฅ๐๐ ๐๐๐ discussed the molecular aspects of stem cells, biomarkers, and infectious agents, emphasizing how ๐๐๐ฃ๐๐๐๐๐ ๐๐ ๐๐๐๐๐๐ข๐๐๐ ๐๐๐๐๐๐๐๐ ๐๐๐ ๐๐ ๐ก๐๐๐๐ ๐๐๐ก๐๐ ๐๐๐ก๐ ๐๐๐๐๐๐ฃ๐๐ ๐๐๐๐๐๐๐ ๐ก๐๐ ๐๐๐ ๐กโ๐๐๐๐๐๐ข๐ก๐๐ ๐ ๐ก๐๐๐ก๐๐๐๐๐ .
๐๐ซ. ๐๐๐ซ๐๐ ๐๐ข๐ฅ๐ฅ๐ ๐. ๐๐๐ฉ๐ข๐ซ๐จ๐ฌ๐จ shared updates on the ๐ฟ๐๐๐ด๐
๐๐ ๐๐๐๐๐๐๐ก, highlighting efforts to strengthen research and surveillance for leprosy in the Philippines. ๐๐ซ. ๐๐ก๐๐ซ๐ข๐๐ก ๐๐๐ข๐ง๐ ๐. ๐๐ ๐๐๐ณ-๐๐ข๐ฅ๐๐ฏ๐ shared updates from the ๐ท๐ธ๐น๐ธ๐ด๐ ๐ป๐๐ ๐๐ก๐ข๐๐ฆ, a research initiative that investigates the determinants of oncogenic human papillomavirus (HPV) infection among Filipino women to advance molecular risk assessment and inform strategies for cervical cancer prevention. Meanwhile, ๐๐ซ. ๐๐๐ซ๐ข๐ ๐๐๐ข๐ง๐ ๐. ๐๐๐ฅ๐ฅ๐๐ง๐ญ๐ featured updates on the ๐
๐ธ๐๐๐๐-๐๐ป ๐๐๐๐๐๐๐ก, which focuses on the surveillance and characterization of emerging viral pathogens to enhance the country's preparedness for infectious disease threats.
Further highlighting the breadth of ongoing research, ๐๐ซ. ๐๐ง๐ ๐๐จ๐ฒ ๐. ๐๐๐๐ฎ๐-๐๐จ๐ณ๐๐ง๐จ presented work on ๐ป๐ผ๐ ๐๐๐๐ข๐๐๐โ๐๐๐๐ก๐ฆ๐๐๐๐ to identify potential therapeutic targets, while ๐๐ซ. ๐๐ก๐ซ๐ข๐ฌ๐ญ๐ข๐๐ง ๐. ๐
๐ซ๐๐ง๐๐ข๐ฌ๐๐จ shared insights into the ๐๐ฃ๐๐๐ฃ๐๐๐ ๐๐๐๐๐๐๐๐ ๐๐๐ ๐๐๐๐๐๐ข๐๐๐ ๐๐๐๐๐๐๐๐๐๐๐๐ฆ ๐๐ ๐๐ข๐๐ก๐๐๐๐ข๐-๐๐๐ ๐๐ ๐ก๐๐๐ก and hypervirulent ๐พ๐๐๐๐ ๐๐๐๐๐ ๐๐๐๐ข๐๐๐๐๐๐.
The VIROH Collaborative Symposium provided a valuable platform for interdisciplinary collaboration, scientific exchange, and meaningful discussions on current and emerging challenges in infectious diseases. Through initiatives like this, the MD-PhD (Molecular Medicine) Program continues to foster collaboration and advance research that bridges basic science and clinical practice to improve human health.
๐ธ Photo credits: Jericho Paolo Mabansag